Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

What is concordance?

By Marjorie Weiss and Nicky Britten

Concordance seems to mean different things to different people. For some, it is merely the latest in a series of terms used to describe compliance and, more recently, adherence. For others, it is a radical shift in the way we think about how patients take medicines. Our aim is to describe what we think concordance is about, how it differs from previous ways of thinking about medicine-taking, and the implications for health care professionals.

Concordance is fundamentally different from either compliance or adherence in two important areas: it focuses on the consultation process rather than on a specific patient behaviour, and it has an underlying ethos of a shared approach to decision-making rather than paternalism. Concordance refers to a consultation process between a health care professional and a patient.

GSK teaser

Compliance refers to a specific patient behaviour: did the patient take the medicine in accordance with the wishes of the health care professional? For this reason it is possible to have a non-compliant (or non-adherent) patient. It is not possible to have a non-concordant patient. Only a consultation or a discussion between the two parties concerned can be non-concordant.

Sharing of power

Crucially, concordance advocates a sharing of power in the professional-patient interaction. Concordance values the patient’s perspective, acknowledging that the patient has expertise in his or her body’s experience of illness and response to treatment. This expertise is different from the professional’s scientific expertise in drug treatment selection but is of equal relevance and value in terms of deciding on best management. A concordant consultation is one that includes both these views in the decision-making process regarding management. This is contrasted with the paternalistic approach underlying compliance: the patient is assumed to take an essentially passive role in the consultation and to be obedient to the health care professional’s advice. Paternalism is still possible in concordance provided it reflects the patient’s preference for involvement in the decision-making process and that this preference has been actively elicited in the consultation. Health care professionals sometimes assume a patient wants a paternalistic approach — that they should make the decision on how best to treat them. However, research suggests that professionals are often unable accurately to “guess” a patient’s preferred role in decision making.1 It would seem that the best way to find out if patients want to be involved in decision making is to ask them.

Why do we need concordance? Put simply, the older models of adherence have had only a limited effect on patient medicine-taking behaviour. A recent review of adherence2 concluded that the full benefits of medication cannot be realised at currently achievable levels of adherence, underlining the inadequacies of the paternalistic approach for ensuring the best use of medicines.3 Will concordance ensure a more effective use of medicines — less drug wastage and fewer hospital admissions due to the iatrogenic effects of drugs? We do not know — the impact of concordance on patient outcomes is still unknown. Definitive evidence is difficult to ascertain as the concordance “package”, including its several constituent parts (eg, exploring patient medication concerns, working together with patients to develop a treatment regimen), has rarely been evaluated comprehensively. Most of the evidence to date concerns an evaluation of one or more elements of concordance or the evaluation of an approach allied to concordance, such as “patient-centredness” or “shared decision-making”. Nonetheless, a recent systematic review of the literature relevant to concordance found that two-way communication between patients and professionals about medicines led to improved satisfaction with care, knowledge of the condition and treatment, adherence, health outcomes and fewer medication-related problems.4

Not all health care professionals will welcome concordance; some will have reservations about giving the patient’s view primacy. It is possible for patients to reject what may be considered (by the professional) to be best clinical practice even when they have been fully informed as to the nature and consequences of this decision. In these situations, concordance does not detract from the autonomy of the health care professional to document such events fully or refuse to supply or prescribe a medicine in situations considered to be pharmaceutically unsafe. Even so, health care professionals may believe they are at risk of litigation should a patient who has refused best treatment suffer an adverse event as a result. However, research evidence suggests this is unlikely. Levinson et al conducted a study among physicians who had a history of previous malpractice claims and those with no previous malpractice history. They found that physicians with no previous history of malpractice claims had better communication consultation skills, using more facilitative talk such as soliciting the patient’s opinion and encouraging them to talk.5 In this context, concordance is about raising to a level of explicitness those decision making processes, by both the patient and health care professional, which were previously unelaborated or occurred outwith the consultation.3

Download the attached PDF to read the full article.

Citation: The Pharmaceutical Journal URI: 10988929

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary information

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.